Eterna Therapeutics stock price
어넥사 테라퓨틱스NASDAQ:ERNA · Nasdaq · Healthcare$2.96+0.00%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Eterna Therapeutics last closed at $2.96 (+0.00%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -0.3×. Its overall grade ranks 736 of 739 stocks in Healthcare.
About this company
Eterna Therapeutics last closed at $2.96 (+0.00%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 736/739
Valuation grade C
Related stocks
- AmgenCompetitor
세포·유전자 치료 및 항암 파이프라인에서 경쟁 가능성이 큼
- Bristol Myers SquibbCompetitor
혈액암·면역항암 분야에서 개발 경쟁 관계
- NovartisCompetitor
CAR-T·세포치료 플랫폼과 희귀질환 치료제 개발 경쟁
About Eterna Therapeutics
- What technical signals does Eterna Therapeutics (ERNA) have?
- Eterna Therapeutics current technical signals: no active technical signal.
- Is Eterna Therapeutics a cup-and-handle pattern?
- No. Eterna Therapeutics has no valid Cup signal right now.
- What published figures are available for Eterna Therapeutics?
- Market cap: $0.93M. Trailing 12 months PER: -0.3×. Latest quarter PBR: 1.09×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Eterna Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy